Part,  Chapter, Paragraph

 1   II,     9.  3.  1    |         intravenous drug users (IDUs) with an HIV co-infection.~ ~
 2   II,     9.  3.  1    |       Diabetes Federation Atlas~IDUs~Injecting drug users~LOH~
 3  III,    10.  2.  1    |       million current or former IDUs are infected with hepatitis
 4  III,    10.  2.  1    |      only injecting drug users (IDUs) and problem opioids users (
 5  III,    10.  2.  1    |     substitution medications.~ ~IDUs are at high risk of experiencing
 6  III,    10.  2.  1    |        an average prevalence of IDUs (current injectors) of between
 7  III,    10.  2.  1    |            HIV prevalence among IDUs shows considerable variation
 8  III,    10.  2.  1(10)|          HIV surveillance among IDUs in Europe consists of two
 9  III,    10.  2.  1    |        in injecting drug users (IDUs) continued in several countries
10  III,    10.  2.  1    |         prevalence of HIV among IDUs. From the available data
11  III,    10.  2.  1    | available data on the number of IDUs and problem drug users it
12  III,    10.  2.  1    |      years, the predominance of IDUs among the new cases of HIV
13  III,    10.  2.  1    |          While HIV infection in IDUs in Europe is mainly concentrated
14  III,    10.  2.  1    | available data on the number of IDUs and problem drug users lead
15  III,    10.  2.  1    |         infections prevalent in IDUs there is hepatitis B. The
16  Key,   Ap5.  0.  0    |    idiopathic~idiosyncratic~idu~idus~ill-health~illicit~illicitly~